3.0.0 4867 2023-01-11T13:44:21Z 2023-01-11T13:44:21Z Senate S 2020-10-26 116 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2020-10-26T20:10:43Z Accelerating Access to Critical Therapies for ALS Act 116 8662 HR 2020-10-23 Referred to the House Committee on Energy and Commerce. Identical bill CRS 2020-10-26 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2020-10-26 Introduced in Senate IntroReferral 10000 9 Library of Congress C001088 Sen. Coons, Christopher A. [D-DE] Christopher Coons D DE A. N M001153 Sen. Murkowski, Lisa [R-AK] Lisa Murkowski R AK 2020-10-26 True S001181 Sen. Shaheen, Jeanne [D-NH] Jeanne Shaheen D NH 2020-11-30 False B001236 Sen. Boozman, John [R-AR] John Boozman R AR 2020-11-30 False K000383 Sen. King, Angus S., Jr. [I-ME] Angus King I ME S. 2020-12-03 False C001047 Sen. Capito, Shelley Moore [R-WV] Shelley Capito R WV Moore 2020-12-03 False G000555 Sen. Gillibrand, Kirsten E. [D-NY] Kirsten Gillibrand D NY E. 2020-12-10 False L000594 Sen. Loeffler, Kelly [R-GA] Kelly Loeffler R GA 2020-12-10 False F000062 Sen. Feinstein, Dianne [D-CA] Dianne Feinstein D CA 2020-12-16 False C001096 Sen. Cramer, Kevin [R-ND] Kevin Cramer R ND 2020-12-16 False J000300 Sen. Jones, Doug [D-AL] Doug Jones D AL 2020-12-21 False H001061 Sen. Hoeven, John [R-ND] John Hoeven R ND 2020-12-21 False L000174 Sen. Leahy, Patrick J. [D-VT] Patrick Leahy D VT 2020-12-21 False M001183 Sen. Manchin, Joe, III [D-WV] Joseph Manchin D WV 2020-12-21 False S001191 Sen. Sinema, Kyrsten [D-AZ] Kyrsten Sinema D AZ 2020-12-30 False M000934 Sen. Moran, Jerry [R-KS] Jerry Moran R KS 2020-12-30 False Health Advisory bodies Congressional oversight Drug safety, medical device, and laboratory regulation Drug therapy Government information and archives Health care coverage and access Health care quality Health information and medical records Health programs administration and funding Health promotion and preventive care Medical research Medical tests and diagnostic methods Neurological disorders Public contracts and procurement Research administration and funding Research and development Health 00 2020-10-26 Introduced in Senate 2020-12-28T16:58:52Z Accelerating Access to Critical Therapies for ALS Act

This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions.

The Department of Health and Human Services (HHS) shall award grants to eligible entities to support research on and facilitate access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other severely debilitating neurodegenerative diseases.

HHS shall also establish the Collaborative for Neurodegenerative Diseases, which shall support the development and regulatory approval of drugs that address ALS and other rare neurodegenerative diseases.

]]> Accelerating Access to Critical Therapies for ALS Act Display Title Accelerating Access to Critical Therapies for ALS Act Short Title(s) as Introduced Accelerating Access to Critical Therapies for ALS Act Introduced in Senate IS Official Title as Introduced A bill to direct the Secretary of Health and Human Services to support research on, and expanded access to, investigational drugs for amyotrophic lateral sclerosis, and for other purposes. Introduced in Senate IS Introduced in Senate 2020-10-26T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s4867is/xml/BILLS-116s4867is.xml 2020-10-26 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.